Literature DB >> 24326240

Incidental dural tear in cervical spine surgery: analysis of a nationwide database.

Hiroyuki Yoshihara1, Daisuke Yoneoka.   

Abstract

STUDY
DESIGN: This was a retrospective study.
OBJECTIVE: To report the incidence of incidental dural tear (DT) in cervical spine surgery, risk factors, and in-hospital patient outcomes on a national level. SUMMARY OF BACKGROUND DATA: DT during cervical spine surgery is not as common as that during lumbar spine surgery; however, DT is still a difficult complication.
METHODS: Clinical data were obtained from the US Nationwide Inpatient Sample for 2009. Patients who underwent cervical spine surgery were identified and divided into those with and without DT according to the International Classification of Diseases, 9th revision, Clinical Modification codes. The patient and health care system-related demographic data were retrieved. The incidence of DT and patient outcomes were analyzed. A multivariate logistic regression analysis was performed to identify the risk factors for DT.
RESULTS: The incidence of DT was 0.45% (855/190,021). The multivariate analysis revealed that a diagnosis of myelopathy and ossification of the posterior longitudinal ligament; posterior approach, anterior and posterior approach; and insurance status were the significant risk factors for DT. Comparison between patients with and without DT showed that those with DT had significantly higher overall in-hospital complications (21.6% vs. 7.3%), longer hospital stays (6.0 vs. 3.2 d), a lower proportion who were discharged home routinely (66.3% vs. 83.9%), increased total hospital costs ($96,424 vs. $62,416), and similar in-hospital mortality (0.6% vs. 0.4%).
CONCLUSIONS: The incidence of DT in cervical spine surgery was 0.45% in the United States. The risk of DT was highest with a primary diagnosis of the ossification of the posterior longitudinal ligament (58.4 times). DT significantly increased the rate of in-hospital complications and health care burden.

Entities:  

Mesh:

Year:  2015        PMID: 24326240     DOI: 10.1097/BSD.0000000000000071

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  6 in total

1.  Choice and management of negative pressure drainage in anterior cervical surgery.

Authors:  Qi-Hang Su; Kai Zhu; Yong-Chao Li; Tao Chen; Yan Zhang; Jun Tan; Song Guo
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

2.  A new parallel closing mechanism for the laminectomy rongeur makes it significantly more precise: a biomechanical and mechanical comparison study.

Authors:  Fabrice Alexander Külling; Lukas Ebneter; Georg Stefan Rempfler; Vilijam Zdravkovic
Journal:  Eur Spine J       Date:  2017-10-24       Impact factor: 3.134

3.  Suitability of Administrative Databases for Durotomy Incidence Assessment: Comparison to the Incidence Associated With Bone-Removal Devices, Calculated Using a Systemic Literature Review and Clinical Data.

Authors:  Robert Pflugmacher; Angelo Franzini; Shaked Horovitz; Richard Guyer; Ely Ashkenazi
Journal:  Int J Spine Surg       Date:  2018-08-31

Review 4.  Anterior Cervical Spine Surgery for Degenerative Disease: A Review.

Authors:  Taku Sugawara
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-06-29       Impact factor: 1.742

5.  Ossification of the Posterior Longitudinal Ligament: Surgical Approaches and Associated Complications.

Authors:  Jeffery Head; George Rymarczuk; Geoffrey Stricsek; Lohit Velagapudi; Christopher Maulucci; Christian Hoelscher; James Harrop
Journal:  Neurospine       Date:  2019-09-30

6.  Risk factors for incidental durotomy during posterior open spine surgery for degenerative diseases in adults: A multicenter observational study.

Authors:  Hisatoshi Ishikura; Satoshi Ogihara; Hiroyuki Oka; Toru Maruyama; Hirohiko Inanami; Kota Miyoshi; Ko Matsudaira; Hirotaka Chikuda; Seiichi Azuma; Naohiro Kawamura; Kiyofumi Yamakawa; Nobuhiro Hara; Yasushi Oshima; Jiro Morii; Kazuo Saita; Sakae Tanaka; Takashi Yamazaki
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.